| | | 62627 | | 12.09.2013 | | Novo Nordisk Pharma AG | | | | | | | | | | | | | 70000. | | | | 07.06.10. | | IPro |
| | Seq.-nr. | Préparation | Description | Forme galénique | Classe d'ATC | |
|---|
| 01 | Ryzodeg Penfill | Injektionslösung | Solution injectable (Insulinum Degludecum 420 , Nmol 0 , Insuline Aspart 180 ) | A10AD06 | IPat |
|
|
